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Abstract
The assessment of oocyte quality in human in vitro fertilization (IVF) is getting increasing attention
from embryologists. Oocyte selection and the identification of the best oocytes, in fact, would help
to limit embryo overproduction and to improve the results of oocyte cryostorage programs.
Follicular fluid (FF) is easily available during oocyte pick-up and theorically represents an optimal
source on non-invasive biochemical predictors of oocyte quality. Unfortunately, however, the
studies aiming to find a good molecular predictor of oocyte quality in FF were not able to identify
substances that could be used as reliable markers of oocyte competence to fertilization, embryo
development and pregnancy. In the last years, a well definite trend toward passing from the
research of single molecular markers to more complex techniques that study all metabolites of FF
has been observed. The metabolomic approach is a powerful tool to study biochemical predictors
of oocyte quality in FF, but its application in this area is still at the beginning. This review provides
an overview of the current knowledge about the biochemical predictors of oocyte quality in FF,
describing both the results coming from studies on single biochemical markers and those deriving
from the most recent studies of metabolomics
Background
The assessment of oocyte quality is rapidly becoming one
of the major objectives of embryologists in human in-
vitro fertilization (IVF). In fact, although classical IVF does
not include any process of oocyte selection and only
embryos (sometimes zygotes) undergo selection, the gen-
eral trend toward limiting embryo "overproduction" and
the rapidly improving results of oocyte cryostorage,
together with the restrictive legal rules introduced in some
Countries, have challenged embryologists to identify cri-
teria to select, among all oocytes retrieved, the best
oocytes to inseminate.
Multiple methods of oocyte selection have been pro-
posed. The study of oocyte morphology is very popular,
being relatively quick and simple; however, it leads to
identify more frequently "negative" than "positive" pre-
dictors of oocyte quality, and overall is not fully satisfac-
tory (for a comprehensive review: [1]). The same concepts
may be applied to studies on polarizing microscopy anal-
Published: 4 May 2009
Reproductive Biology and Endocrinology 2009, 7:40 doi:10.1186/1477-7827-7-40
Received: 25 August 2008
Accepted: 4 May 2009
This article is available from: http://www.rbej.com/content/7/1/40
© 2009 Revelli et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Reproductive Biology and Endocrinology 2009, 7:40 http://www.rbej.com/content/7/1/40
Page 2 of 13
(page number not for citation purposes)
ysis (for a review: []. Some authors have studied the
expression of genes in the granulosa cells or in the oocyte
itself, looking for specific molecular markers of oocyte
quality (see the review [2]). Polar body biopsy is some-
where used to screen oocytes with chromosomal defects
deriving from errors in the two meiotic divisions (see the
review [3]). Most of these techniques are quite compli-
cated, require expensive laboratory equipment and time-
consuming procedures, and consequently are not cur-
rently applicable in the clinical practice.
Follicular fluid (FF) provides a very important microenvi-
ronment for the development of oocytes. FF is a product
of both the transfer of blood plasma constituents that
cross the blood follicular barrier and of the secretory activ-
ity of granulosa and thecal cells [4]. It is reasonable to
think that some biochemical characteristics of the FF sur-
rounding the oocyte may play a critical role in determin-
ing oocyte quality and the subsequent potential to achieve
fertilization and embryo development. The analysis of FF
components may also provide information on metabolic
changes in blood serum, as the circulating biochemical
milieu may be reflected in the composition of FF [5].
FF is easily available as it is aspirated together with the
oocyte at the time of OPU. In the last years, the study of
FF content has been conducted by assaying one or more
substances in the fluid derived from individual follicles
and by relating it (them) to the fate of the egg coming
from that specific follicle. For study purposes, in order to
correlate FF substances with oocyte quality, it is impera-
tive that each individual follicle is aspirated individually.
The procedure of separated, single follicle aspiration is
uncomfortable both for the patient and for the physician
because multiple vaginal punctures are required, with
increased risk of vaginal bleeding and increased patient
discomfort. Moreover, needle flushing with culture
medium after every follicular puncture has to be per-
formed in order to be sure that the oocyte is effectively
retrieved from each specific follicle; flushing must be
made with standard volumes of buffered solution in order
to obtain a known dilution of FF substances. Another rel-
evant problem in studies estimating oocyte quality in rela-
tion to FF composition is that oocyte nuclear maturity is
assessed shortly after oocyte recovery only during ICSI
cases. Oocyte maturity in IVF is usually assessed only the
following day, and a mature oocyte could have completed
the nuclear maturation when cultured. This could bias the
results. Finally, it is not completely clear if the FF concen-
tration of a given substance is a variable related to the
quality of the follicle (and therefore possibly reflecting the
quality of the oocyte inside it) or to the clinical character-
istics of the patient, such as age, smoking habit or type of
ovarian stimulation.
Overall, a clear correspondence between specific FF bio-
chemical characteristics and measurable oocyte quality-
linked, embryo-related variables has not been established
to date. In the last years, the research in this area has pro-
gressed toward a more complex type of molecular analy-
sis, metabolomics, that is the analysis of all substances
contained in a biological fluid. This review provides an
overview of the current knowledge about the biochemical
predictors of oocyte quality in FF, describing both the
results coming from studies on single biochemical mark-
ers and those deriving from the most recent studies of
metabolomics. The chemical constituents of FF have been
grouped in the following categories: a) hormones; b)
growth factors of the Transforming Growth Factor-beta
(TGF-beta) superfamily; c) other growth factors and inter-
leukins; d) Reactive Oxygen Species (ROS); e) anti-apop-
totic factors; f) proteins, peptides and amino-acids; g)
sugars; h) prostanoids.
Hormones
Gonadotropins
Intrafollicular concentrations of FSH and LH are affected
by their circulating levels: in IVF cycles the serum levels are
determined by the amount of exogenously administered
gonadotropins and by the degree of pituitary suppression
(relevantly reducing the endogenous gonadotropin secre-
tion).
High FF concentrations of FSH [6], hCG [7], and LH [8]
have been reported to promote oocyte maturation and to
be associated with eggs having a high chance of fertiliza-
tion. These findings are confirmed by immunohistochem-
istry studies that stained granulosa cells for hCG: oocytes
that subsequently fertilized had, in fact, significantly more
granulosa cells immunobound to hCG than non-fertiliza-
ble oocytes [9]. FF LH was observed to be consistently
higher in follicles containing oocytes that resulted in
embryos leading to successful IVF attempts [10].
It appears that gonadotropins play an important role in
the secretion of several substances by granulosa cells (e.g.
hyaluronic acid), in turn affecting oocyte development
and maturation. They may also act synergistically with
estradiol (E2) in enhancing cytoplasmic maturation of the
egg and, via cyclic AMP (cAMP) secretion, control oocyte
meiosis: higher levels of gonadotropins would improve
these processes and lead to better oocytes, better embryos
and improved pregnancy rate. Notably, GH seems to play
a similar (and may be synergic with gonadotropins) role
[10].
Growth hormone (GH)
GH is known to enhance the FSH-dependent E2 produc-
tion by granulosa cells [11] as well as the formation ofReproductive Biology and Endocrinology 2009, 7:40 http://www.rbej.com/content/7/1/40
Page 3 of 13
(page number not for citation purposes)
FSH and LH receptors in these cells [12]. GH synthesis
occurs also in the follicle [13], thus GH could act sinergi-
cally with gonadotropins increasing the "estrogenicity" of
the follicle microenvironment, in turn leading to better
oocytes.
Although GH has been identified in FF, a clear association
between intrafollicular GH levels and pregnancy has not
been found. Mendoza [10] found a higher GH concentra-
tion in follicles containing oocytes that generated
embryos leading to successful IVF attempts, but Tarlatzis
[14] found the opposite: lower GH concentration in FFs
from IVF pregnant women when compared to non-preg-
nant patients.
Prolactin (PRL)
PRL content was reported to be higher and cAMP lower in
the FF of fertilized oocytes as compared to unfertilized
eggs [15]. A link between high PRL [16] and low cAMP
[17,18] levels in FF, fertilization and successful pregnancy,
was observed in some studies, but was not confirmed by
others [19-23]. Therefore, at present FF PRL is not consid-
ered a reliable marker of oocyte quality.
Estrogens, progesterone (P) and androgens
It is well known that a predominantly intrafollicular estro-
genic environment is associated with good follicular
growth and has anti-atresia effects. In addition, E2
enhances the cytoplasmic maturation of oocytes via a
direct non-genomic action at the plasma membrane level,
in turn inducing extracellular calcium influx into the cell
and a specific pattern of Ca2+ oscillations [24].
Elevated E2 and E2/P ratio in FF indicate a more advanced
stage of oocyte maturation and have been repeatedly
found to be associated with a higher chance of achieving
pregnancy [14,17,19,22,25-29]. This observation, how-
ever, was not confirmed by other studies [6,20,23,30,31].
There is also conflicting evidence regarding the meaning
of progesterone levels in FF. Several authors found that a
high FF P concentration (or a low E2/P ratio) was predic-
tive of subsequent implantation and pregnancy [32-35],
and considered it as a reflection of progressive follicle
luteinization and reduction of aromatase activity linked
to the achievement of the final egg maturation. On the
other side, however, oocytes from follicles having high FF
P were frequently found in association with postmature
oocytes that fertilized abnormally and gave rise to multi-
pronuclear embryos [36]. It seems that while an optimal
exposure to P has positive effects over oocyte characteris-
tics, an excessive exposure leads to a rapid worsening of
the cell's quality; a clear knowledge of the threshold at
which P begins to damage the oocyte is presently lacking.
Elevated FF androgen levels (testosterone) were associated
with lower quality oocytes, and in particular with oocytes
showing a trend toward lower cleavage rates after fertiliza-
tion [37]. E2/T ratio was also reported to be higher in
pregnancy-associated follicles [38,39]. Taken together,
these data seem to indicate that a low estrogen/androgen
ratio in FF may be associated with early follicular atresia,
which negatively affects the viability of the enclosed
oocyte and limits the chances of fertilization and preg-
nancy. Indeed, the notion that a predominantly andro-
genic intrafollicular environment may lead to follicular
atresia is well accepted, but at the same time it is widely
accepted that a certain amount of intrafollicular andro-
gens is needed to obtain optimal follicular growth. In fact,
in IVF cycles with unsatisfactory ovarian response to FSH,
addition of LH (and thus stimulation of androgen synthe-
sis by theca cells) has been found to improve follicle
growth and oocyte maturation [40,41].
Corticoids
Corticoids in the FF have been supposed to be important
to achieve final oocyte maturation and subsequent
embryo implantation by authors that observed that a high
FF cortisol/cortisone ratio was associated with the likeli-
hood to become pregnant in IVF [42,43].
Interestingly, adjuvant corticoid therapy during IVF was
advocated to promote a better ovarian response and the
retrieval of more mature oocytes [44]. However, a recent
paper in which prednisolone was administered in associ-
ation with acetylsalicylic acid as an adjuvant treatment
during IVF cycles failed to detect any advantage in terms
of oocyte fertilization, embryo implantation and preg-
nancy in treated women [45].
Growth factors of the Transforming growth factor-beta 
(TGF-beta) superfamily
Inhibin and Activin
Inhibins are produced by granulosa cells and their FF level
reflect the number and activity of the granulosa cells of
each follicle; in the FF, inhibin A increases while inhibin
B decreases during the follicular phase [46,47]. FF inhibin
A levels are significantly higher in patients with endome-
triosis [48,49].
A recent prospective study showed that higher levels of
inhibin A and B were associated with the likelihood to
retrieve oocytes at the time of OPU, but not with oocyte
quality and fertilization competence [47]. Similarly, Fried
[50] observed that inhibin B in FF and serum was strongly
correlated to the number of oocytes retrieved, but not
with the IVF outcome, so that inhibin could be considered
as a marker of ovarian response, but not of oocyte or
embryo quality.Reproductive Biology and Endocrinology 2009, 7:40 http://www.rbej.com/content/7/1/40
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Chang [51] found that inhibin B in FF may serve as an
effective marker of follicular development; he also
showed a significant correlation between inhibin B levels
in FF and embryo scores on days 2 and 3, so he considered
inhibin B a useful predictor of quality of the embryo.
Another study reached similar conclusions: Ocal [52]
found that high levels of inhibin A and B in the FF were
associated withy increased fertilization and pregnancy
rates.
Lau [46], on the other hand, found a positive correlation
between good quality oocytes and FF levels of Activin A,
but not with inhibins A and B. His researches were not fur-
ther developed, so the role of Activin A as a marker of
oocyte quality and its relationship with inhibin family
needs further investigation.
Anti-mullerian hormone (AMH)
Data on AMH levels in relation to oocyte quality are still
contradictory. Serum levels of AMH between 1.66 and
4.52 ng/mL-1 were found to be associated with high qual-
ity oocytes [53] and with good morphology embryos [54].
Cupisti [55] found that AMH levels in individual follicles
were inversely correlated with the maturation and devel-
opmental potential of oocytes. On the contrary, Taka-
hashi [56] observed that oocytes were more likely to be
fertilized when their follicle was able to produce high lev-
els of AMH, as FF AMH levels from follicles with fertilized
oocytes were more than 3 times higher than from follicles
with non-fertilized eggs.
Bone morphogenetic protein-15 (BMP-15)
BMP-15 was found to influence oocyte maturation and
quality. Higher BMP-15 levels were observed in the FF of
eggs that fertilized and cleaved in comparison with the
unfertilized or uncleaved [57]. In the same study, intrafol-
licular BMP-15 levels were also shown to be positively cor-
related to FF estradiol levels in individual follicles. These
results still need to be confirmed in larger studies.
Other growth factors and interleukins
Insulin-like growth factors (IGF)
Insulin-like growth factors I and II (IGF-I and -II) are
polypeptides that promote cell proliferation and differen-
tiation in several tissues; their biological availability is reg-
ulated by a family of IGF-binding proteins (from IGFBP-1
to IGFBP-6).
The intrafollicular levels of IGF-II, IGFBP-3 and IGFBP-4
were found to be significantly correlated with oocyte ferti-
lization, cleavage, embryo development and embryo mor-
phological score on day 3 [58]. In the same study,
multiple regression analysis showed that the combination
of high FF levels of IGFBP-3 and 4 with low FF levels of
pregnancy-associated plasma protein-A (PAPP-A) was sig-
nificantly correlated with fertilization and embryo devel-
opment.
In other studies, FF levels of both IGF-I and IGFBP-1 were
positively correlated with oocyte quality and maturity
[28,59,60], and the ratio IGF-1/IGFBP-1 was shown to be
significantly higher both in serum and in FF in women
whose IVF was successful [50].
In a recent study, however, IGF-I FF levels were not found
to reflect embryo quality and IVF outcome [61]. Overall,
further studies are needed to estabilish if IGFs and IGF-
BPs have the potential to become useful non-invasive
biomarkers of oocyte quality in the clinical practice.
Other growth factors
The growth factor amphiregulin, that probably mediates
some of the effects of hCG on oocyte maturation, was
recently detected in FF and its levels were inversely related
to the fertilization rate; however, they were not associated
with embryo quality [62].
Similarly in another study, no correlation with embryo
quality and IVF outcome was observed for tumour necro-
sis factor-alpha (TNF-alpha), epidermal growth factor
(EGF), and basic fibroblast growth factor (BFGF) [61].
Interleukins
Pro-inflammatory cytokines can be found in FF as a result
of ovarian local synthesis and release during follicular
maturation and ovulation; for example, FF IL-1beta
derives both from the plasma ultrafiltrate and from the
local synthesis by luteinizing granulosa cells.
A positive correlation was observed between the serum
concentrations of IL-1beta and E2 on the day of hCG
injection [63]. Higher FF IL-1beta levels were associated
with normal fertilization [64], but surprisingly they were
lower in FFs whose oocytes were able to generate better
embryos and successful IVF attempts [10]. It is possible
that IL-1beta leads to cytoplasmic maturation and normal
fertilization, but does not play a role in post-fertilization
embryo development.
In some studies, IL-2 and IL-10 were found to correlate
with specific hormonal milieus within the follicle, but not
with IVF outcome [65-67]. Ledee [68] recently detected
significantly higher levels of IL-2 and interferon (IFN-
gamma) in FFs whose oocytes generated early cleaving
embryos. In the same study, IL-12 levels were higher in
the FF of follicles corresponding to highly fragmented
embryos, and granulocyte colony-stimulating factor (G-
CSF) was particularly elevated in the fluid of follicles cor-
responding to embryos with high implantation potential.Reproductive Biology and Endocrinology 2009, 7:40 http://www.rbej.com/content/7/1/40
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Bili [69] studied the FF levels of IL-1alpha, IL-2, TNF-
alpha and leukotriene B4 (LTB4) and reported that there
was no significant relationship between their individual
FF concentration and oocyte maturity, fertilization and
likelihood of pregnancy. On the other hand, IL-1alpha/
TNF-alpha, IL-1alpha/LTB4, TNF-alpha/LTB4 ratios were
significantly different in the FF of the women who became
pregnant versus the ones who did not. He suggested that
IL-1alpha, TNF-alpha and LTB4 may take part in the proc-
ess of follicle wall degradation, and their concentration in
optimal proportion may reflect a better intrafollicular
milieu able to optimize oocyte development and matura-
tion.
Reactive Oxygen Species (ROS)
ROS and antioxidant factors
Follicular vascularity, intrafollicular oxygen content and
mitochondrial activity are factors sustaining an optimal
oocyte development [70-72]. Studies on follicular vascu-
larization and oxygenation may provide information on
the developmental competence of the respective oocytes.
Oxidative stress may induce DNA damage and trigger
apoptosis. In fact, severely hypoxic follicles contain
oocytes with a high frequency of abnormalities of the mei-
otic spindle, with subsequent increased probability of
aneuploidy in the embryo [73]. Hypoxic follicles that
often contain oocytes with cytoplasmic defects give often
rise to embryos with multinucleated blastomeres [73].
The impact of oxidative stress on oocyte maturation seems
to be deleterious, although its exact role is not fully clari-
fied and, in fact, conflicting results exist.
Surprisingly, some studies found a positive correlation
between FF ROS levels and maturation parameters. ROS
were reported to improve bovine oocyte developmental
potential during in vitro maturation [74], and Attaran
[75] reported that women who become pregnant in IVF
had significantly higher ROS levels in the FF than non-
pregnant patients. On the other side, a supraphysiological
amount of ROS leading to oxidative stress is involved in
the aetiology of defective embryo development [76] and it
was reported that low levels of ROS in FF might represent
a potential marker for predicting success in IVF [75].
It is likely that an optimal balance between oxygen avail-
able to the oocyte and antioxidants is critical to permit
normal meiotic spindle formation and correct chromo-
some alignment; in fact, in the mouse model correct chro-
mosomal alignment was found in follicles with high
oxygen and antioxidant levels [77].
Overall, high ROS levels reflect a wide range of patholog-
ical conditions that affect fertility potential. The deleteri-
ous effect of ROS can be counteracted by scavengers of free
radicals or by endogenous antioxidants, such as the
enzymes superoxide dismutase (SOD) and selenium-
dependent glutathione peroxidase (SeGPx). The presence
of SOD was reported in human FF, and high FF SOD con-
centrations were associated with oocytes that failed to fer-
tilize [78]. In contrast, high levels of SeGPx were found in
follicles that yelded fertilizable oocytes, and lower levels
were related to fertilization failure [79].
Also the pineal hormone melatonin was found to exert an
antioxidant effect protecting oocytes from oxidative stress;
its intrafollicular concentration was shown to be inversely
correlated with that of the oxidation marker 8OH-deoxy-
guanosine; moreover, the administration of 3 mg/day oral
melatonin improved fertilization rate [80].
Overall, the FF total antioxidant capacity (TAC) was found
to be significantly higher in follicles bearing oocytes com-
petent for fertilization than in follicles having non-fertiliz-
able oocytes [81]. TAC, a measurable marker of
antioxidant activity, showed a positive correlation with
embryo quality and with pregnancy rates in IVF [82]. The
presence of higher TAC amounts in FF than in serum
probably reflects the antioxidant activity of granulosa cells
[79]. Elevated TAC levels would be a marker of mature fol-
licles leading to the growth of high-quality oocytes.
Nitric oxide (NO)
Granulosa cells contain the endothelial isoform of NO
synthase (eNOS) and actively synthesize NO [83]. NO is
a very unstable gas molecule with a very short half-life and
it is hardly measurable with direct methods. However, it is
rapidly transformed into nitrites and nitrates, which, in
turn, may be measured in biological fluids.
FF levels of nitrites and nitrates were observed to be signif-
icantly lower in follicles containing mature oocytes that
fertilized and generated dividing embryos (> 6 cells stage)
[84]; conversely, higher follicular levels of the same mol-
ecules were found to be associated with extended frag-
mentation and lower implantation potential of embryos
[85]. Furthermore, NO concentrations in FF were
observed to be significantly higher in patients with
endometriosis or hydrosalpinx [83], conditions that are
both associated with oocytes of lower fertilization poten-
tial. Interestingly, an up-regulation of serum NO was asso-
ciated with implantation failure in patient with tubal or
peritoneal factor infertility [85].
Taken together, these data suggest that an excessive pro-
duction of NO in the microenvironment surrounding the
oocyte could trigger apoptosis within the follicle before
fertilization, thus affecting oocyte development. FF con-
centrations of nitrites/nitrates could eventually be used a
negative markers of oocyte quality; however, their assess-
ment is rather tricky and their intrafollicular levels wereReproductive Biology and Endocrinology 2009, 7:40 http://www.rbej.com/content/7/1/40
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not found to correlate with IVF outcome [86]; thus, it is
unlikely that the measurement of NO or its derivates will
be used to identify optimal oocytes.
Vascular Endothelial Growth Factor (VEGF)
VEGF has a potentially important role affecting perifollic-
ular angiogenesis and regulating intrafollicular oxygen
levels. FF VEGF levels are significantly correlated with the
grade of perifollicular vascularity [87].
A prospective study reported that FF VEGF concentration
was significantly higher when the oocyte failed to fertilize
[88]; furthermore, high FF VEGF levels have also been
associated with poor embryo morphology [89] and poor
conception rates in IVF [73].
The reason why VEGF FF levels appear to be negative
markers of oocyte quality could be the activation of VEGF
synthesis in response to hypoxia within the oocyte-cumu-
lus complex. An hypoxic status at this level could be
responsible on one side for the high intrafollicular con-
centrations of the peptide, on the other side for the low
quality of the oocytes. In IVF programs that include oocyte
selection, VEGF level in FF could be used as an index to
exclude oocytes that developed in an hypoxic follicle, but
until now FF VEGF assay, that is time-consuming and
expensive, has not been introduced in the clinical practice.
Anti-apoptotic factors
Apoptotic changes in the follicle's microenvironment can
affect IVF outcome: high levels of apoptotic granulosa
cells were associated with low quality oocytes, whereas
low levels were associated to embryos of good quality
[90]. The incidence of apoptosis in cumulus granulosa
cells was found to be significantly higher in older women,
and lower in follicles of younger IVF patients who become
pregnant; moreover, comparing granulosa cells of a single
follicle to the IVF outcome of the corresponding oocyte,
embryo quality showed a negative correlation with the
level of cumulus cells apoptosis [91].
The activation of specific cellular pathways, such as those
involving Tumor Necrosis Factor (TNF) and Fas-ligand
(Fas-L), is very important in determining apoptosis within
the follicle; even the oocyte itself expresses some receptors
that are specific of the apoptotic pathways, such as TNF-R
[92] and Fas [93].
Both soluble FAS (sFas) and its ligand sFas-L have been
detected in FF where they probably regulate both follicu-
lar atresia and oocyte maturation during folliculogenesis;
it has been reported that sFas concentrations are signifi-
cantly higher in FFs containing mature oocytes [94,95],
whereas low sFas and high sFas-L concentrations are
related to high apoptosis level in the follicle and poor
oocyte quality [96].
Nevertheless, when sFas was measured in the oocyte-
cumulus colture medium its concentration was inversely
related to embryo quality [95], and both sFas and sFas-L
concentrations in FF of patients with PCO were not signif-
icantly different between patients who achieved or not
pregnancy, demonstrating a lack of predictive value
towards oocyte quality [97]. The overall analysis of data
indicates that sFas concentration in FF is not a reliable
marker of the quality of the oocyte and of the embryo
obtained from it.
Proteins, peptides and amino-acids
FF contains several proteins that derive from blood
plasma or are secreted both by granulosa and thecal cells
[98]. The analysis of protein composition of FF aimed at
identifying molecules that could be used as markers of
good follicular development in order to optimize oocyte
selection processes [99].
The study of proteinic components in FF have been made
by detecting specific proteins and correlating them to
oocyte quality. In the last years, more complex molecular
techniques have been introduced; they allow to simulta-
neously study dozens of proteins and peptides in a biolog-
ical fluid and allow the so-called "proteomics".
The major problem in the proteomic analysys of complex
biological fluids is that their protein composition is very
complicated and dynamic; as a consequence, sensitive
and high-resolving protein separation techniques are
needed. The most popular approach to FF proteomics is
presently based on two-dimensional gel electrophoresis
followed by protein digestion and mass spectrometry
[100]. Recently, easier techniques based on protein pre-
fractionation by isoelectric focusing and subsequent
nanoliquid chromatography and mass spectrometry have
been proposed and applied to the study of FF proteins
[101]. Overall, however, the general understanding about
proteins and their role in follicular growth and oocyte
maturation is still quite limited.
Alpha-Fetoprotein, CEA and CA-125
FF levels of alpha-Fetoprotein (alpha-FP), CEA and CA-
125 were not found to change significantly from fluids
containing oocytes able to be fertilized or not [102]. Dif-
ferent follicles of the same patient showed a wide range in
the concentrations of the three antigens and none of them
was related to oocyte quality [103]. In another study, CA-
125 intrafollicular levels were not found to be related
either to a specific follicular hormone or to the outcome
of the IVF cycle [104].
Antigen CD44
CD44 is a membrane-integrated protein that can be shed
from the cell's surface as soluble CD44 (sCD44) in several
body fluids, including FF. The administration of hCG mayReproductive Biology and Endocrinology 2009, 7:40 http://www.rbej.com/content/7/1/40
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induce shedding of CD44 from granulosa cells and in fact
FF sCD44 concentration varies according to the concen-
tration of hCG. The concentration of sCD44 in FF was
found to be lower in follicles containing oocytes that were
subsequently fertilized and gave rise to good-quality
embryos [105]. Whether or not high CD44 levels may
directly adversely affect the oocyte is not known by now.
Alpha1-antitrypsin
Early studies indicated that follicles with mature oocytes
contain lower levels of FF alpha-1-antitrypsin [106,107],
therefore this protein could be a negative marker of oocyte
quality. The research concerning the role of FF alpha-1-
antitrypsin, however, has not been further developed in
the last twenty years. It is unlikely that this substance will
ever play a role in oocyte selection.
Leptin
FF leptin and soluble leptin receptor levels are inversely
correlated with each other; FF leptin correlates directly
with intrafollicular E2, P and androstenedione concentra-
tions, whereas soluble leptin receptor levels are related to
activin and follistatin intrafollicular concentrations [108].
Follicular leptin was also reported to inversely correlate
with follicular pO2, appearing to be a marker of follicular
hypoxia, suboptimal oocyte development [89] and low
chance of pregnancy [109,110]. Other studies suggested
that leptin levels in FF could not be considered a marker
of oocyte quality and developmental potential [111]. In
recent studies, leptin was shown to be positively corre-
lated with the fertilization rate [112], weekly associated
with embryo morphological score, but not with the IVF
outcome [61]. At present, leptin concentration in FF does
not appear to precisely reflect oocyte quality and to be
useful for oocyte selection.
Endothelin-2
The mean concentration of endothelin-2 (but not
endothelin-1) was reported to be significantly higher in
FFs that contained oocytes that could be fertilized and
cleave [113]. FF endothelin-2 levels were not correlated
with inhibin, estradiol, progesterone or FSH, but signifi-
cantly correlated with IGF-1 levels, indicating a possible
synergistic effect with IGF-1 system in promoting FSH
activity inside the follicle [113].
Plonowski [114] suggested that Endothelin-2 affects
oocyte quality preventing the granulosa cells luteinization
and progesterone synthesis; as a consequence, endothe-
lin-2 could represent a positive marker of correctly-timed
oocyte maturation.
Oocyte maturation inhibitor (OMI)
During normal follicle maturation it was observed a
decline in FF OMI concentration as soon as the oocyte
become mature and fertilizable. FFs yielding mature and
fertilizable oocytes were found to have significantly lower
OMI activity. Follicles with high OMI activity yielded
immature or atretic oocytes, or oocytes with fractured
zona pellucida [115]; it was postulated that in case of
abnormal maturation or altered oocytes, FF OMI levels
could remain higher and represent a negative marker of
oocyte quality. However, OMI was the name attributed to
an activity found in FF, but a corresponding protein was
never identified. Thus, this paragraph has mainly an his-
torical interest since research on OMI was not continued
after the middle of 80's.
Homocysteine (HCY)
HCY is a metabolite of methionin with several functions
not yet completely understood. It was observed that
oocytes exposed to low HCY concentrations had better
quality and degree of maturity [116,117]. Since adminis-
tration of folic acid lowers HCY concentration in both FF
and serum, this could explain the positive effect of pre-
conceptional folic acid treatment on IVF outcome.
Beta-endorphin (beta-EP)
Data on the relationship between FF beta-EP and oocyte
quality are controversial and inconclusive. Beta-endor-
phin levels were found to be higher in FF from follicles
which contained oocytes that subsequently fertilized
[118]. In contrast, another study observed that follicles
containing mature oocytes had lower beta-EP content and
were associated with oocytes able to form embryos with
better developmental attitude [119].
Lactoferrin
Lactoferrin is an iron-binding glycoprotein originally iso-
lated from milk. It is present in detectable amounts in FF
and it was found to be significantly more concentrated in
larger follicles yelding good quality oocytes able to allow
fertilization and development to good quality embryos
[120]. This recent observation needs to be further vali-
dated.
Angiotensin II (ATII)
FF ATII levels were found to be negatively correlated with
FF progesterone [121]. However, another study found no
correlation between ATII concentration in individual FFs
and the ability of the corresponding oocyte to be fertilized
[122].
Prorenin
Prorenin biosynthesis and secretion within the ovary are
regulated by gonadotropins; higher prorenin FF levels are
found in follicles containing immature oocytes, and no
conception was noticed from oocytes originating from
follicles with prorenin levels above the normal rangeReproductive Biology and Endocrinology 2009, 7:40 http://www.rbej.com/content/7/1/40
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[123]. Prorenin could be a negative marker of oocyte qual-
ity, but this hypothesis needs confirmation.
Amino-acids
Some amino-acids of FF, such as alanine and glycine, have
shown a good predictive value on IVF outcome in the
bovine model [124]. In humans, D-aspartic acid concen-
trations in FF were found to directly correlate with the per-
centage of good morphology, MII oocytes and with the
fertilization rate [125]. This research area looks promis-
ing, but further, more complete data are needed.
Sugars
Hyaluronan
Hyaluronan is a disaccharide composed of D-glucuronic
acid and D-N-acetylglucosamine; it is contained in the
cumulus extracellular matrix where it is involved in the
detachment of the cumulus-oocyte complex that becomes
freely floating in FF just before ovulation.
FF concentration of hyaluronan was positively related to
the level of apoptosis in granulosa cells, and it was higher
in follicles containing non-fertilized oocytes [126]. How-
ever, this observation was not confirmed and no signifi-
cant relationship was found between FF hyaluronan and
the maturity and fertilizability of the oocytes [127].
Myo-inositol
High levels of FF myo-inositol were positively correlated
with FF E2 levels and with the quality of the embryos
derived from the corresponding oocytes [128]. Myo-inosi-
tol, however, is not considered more reliable than E2 itself
in indicating the quality of the oocyte.
Prostanoids
Prostaglandin F2alpha, secreted by granulosa cells under
the stimulation exerted by gonadotropins, was proposed
as a biochemical marker of oocyte quality, as it was found
to be higher in the FF of follicles whose oocytes were sub-
sequently fertilized [6]. Moreover, both PGE2 and
PGF2alpha concentration in FF were found to be higher in
follicles containing mature oocytes [129].
In another study, the PGE2/PGF2alpha ratio in FF was
found to be significantly lower in IVF cycles when preg-
nancy was obtained than in unsuccessful IVF cycles; this
ratio could reflect the optimal conditions within the folli-
cle to give an oocyte of high quality [130].
It must be remembered that prostaglandins have a very
short half-life and their concentration in biological fluids
changes very quickly: their measurement is technically dif-
ficult and not available in all laboratories. It is hard to
imagine that prostanoids will be widely used as oocyte
quality predictors in the clinical practice.
Physicochemical features of FF
Apart from biochemical characteristics, the physicochem-
ical properties of FF have been studied and correlated with
the outcome of the corresponding oocytes.
The spectrophotometric absorbance of human FF in the
visible spectrum shows two distinct peaks at 415 and 455
nm wavelength; it has been observed that oocytes that
subsequently fertilized were more frequently associated
with FFs having significantly higher absorbances at these
two peaks [131,132]. Neither FF viscosity, or FF refractive
index were found to correlate with oocyte maturity or fer-
tilization potential [132].
Metabolomics of FF
In the last years, research is moving away from metabolic
target analysis (restricted to single metabolites) towards
metabolite profiling (the study of selective groups of tar-
get compounds and their metabolic intermediates using a
single analytical technique) and towards the dynamic
study of all low molecular weight metabolites.
Metabolomics studies the small molecules (amino acids,
lipids, nucleotides, signalling molecules, etc.) found in
biological fluids that are produced through the action of
different proteins, in turn expression of gene transcription
and mRNA traduction. Metabolites represent the interface
between the information embodied in the genome and
the functional cell's phenotype. Their number is tipically
lower than the number of genes and proteins in a cell or
in an organism; as a consequence, thorough metabolomic
analysis can be performed in a relatively faster time than
genomic or proteomic analyses.
Metabolomics has been proven to be a consistent and
informative technology for pattern recognition analysis of
several biological systems, and is presently being applied
to the study of human embryos [133-135] and oocytes
[136]. Aim of metabolomic analysis is to identify and
quantify all the metabolites in a biological fluid (e.g. FF)
under given physiological conditions at a certain time
point. The major difficulties in metabolomics are essen-
tially three: a) many metabolites are of labile nature,
chemically complex and have a widely dynamic produc-
tion pattern; b) methods to amplify metabolites (e.g. as
may be done with DNA) and increase sensitivity are lack-
ing; c) metabolomic analysis deals at the same time with
several classes of molecules with different chemical prop-
erties.
The techniques used in metabolomic studies have to be
very sensitive and capable of screening a high number of
molecules in a reasonably short time. At present, mass
spectrometry (MS) techniques, alone or in combination
with liquid chromatography, gas chromatography, capil-Reproductive Biology and Endocrinology 2009, 7:40 http://www.rbej.com/content/7/1/40
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lary electrophoresis or ultra performance liquid chroma-
tography (UPLC) offer the highest efficiency (for a review
see [136]). The preliminary chromatographic step lowers
the number of substances entering the mass spectrometer
facilitating the separation of metabolites and improving
MS data quality; integrated deconvolution algorhythms
applied to informations coming from MS give a more pre-
cise quantification of metabolites [137,138]
Metabolomics of the FF is the dynamic quantitative
assessment of all low molecular weight substances that are
present in FF at a given time [139]. Being the end products
of cell's metabolism, low-molecular weight metabolites
can reveal the response of the follicle to all influences
affecting its development. Metabolites are potentially
more informative than the direct study of gene expression
(genomics), mRNAs (transcriptomes) or proteins (pro-
teomes); in fact, an increased gene activation with conse-
quent mRNA and protein synthesis not necessarily
corresponds to altered cellular function or morphology,
whereas metabolomes reveal the actual functional status
of a biological system and its cells.
Oocyte development is regulated by the transcripts accu-
mulated during the growth phase; gene expression in
oocytes may be studied by microarrays and high-fidelity
RNA amplification techniques which allow the simultane-
ous profiling of thousands of genes, but cannot be used
for oocyte selection because they require cell lysis [140].
Some reports describe RNA analysis of human oocytes
using microarrays (transcriptomics) [141]. All mRNA
molecules need to be translated into proteins or metabo-
lites, that after specific post-translational modifications
become the true markers of cell functionality. Metabolites
represent the final products of cell regulatory processes; it
is now possible to profile the metabolites secreted by the
oocyte into the surrounding medium by investigating the
FF or, alternatively, the compounds secreted by the oocyte
into the culture medium in which it is suspended during
in vitro culture after retrieval ("exometabolomics" or
"secretomics"). The overall metabolic profiling of FF or of
oocyte culture supernatants could be more useful than the
targeted metabolic approach or the study of a selective
class of substances for the assessment of oocyte quality.
More than one metabolite, in fact, is likely to be involved
in determining oocyte's developmental competence, and,
as a consequence, a panel of biomarkers should be con-
sidered for clinical diagnostic purposes.
The most relevant investigations about the assessment of
oocyte quality have been performed in animal models
and have undertaken profiling for a selective class of
metabolites, such as fatty acids [142], amino acids [143],
or sugars [144]. Results are still very preliminary, but it has
emerged that the metabolic profiling of FF collected from
large antral follicles is more homogeneous that the one
obtained with fluids collected from small follicles, reflect-
ing differences in the biochemical profile linked to oocyte
maturational stage [145]. In one of these studies, it has
been observed that oocytes able to absorb larger amounts
of glucose and actively convert it into lactate show the
highest fertilization potential [144]. Other studies have
focused on the evaluation of oocyte metabolism through
the measurement of energy substrates [146] or of oxygen
consumption [147] in culture media. The concentration
of oxygen in the medium containing the oocyte may be
measured by specific and sensitive sensors; it is assumed
to reflect the mitochondrial activity necessary to produce
the energy required for development, and it has been
shown to be related to cell's viability [147].
Overall, the viability and quality of oocytes (and derived
embryos) estabilished by metabolomic tests could repre-
sent stronger predictors for implantation potential than
the classical morphological assessment. Maybe the metab-
olomic analysis of the FF collected at OPU may provide
additional predictive informations about egg quality in
the next future. The predictive value of metabolomic anal-
ysis will be fully realized when new technologies, able to
determine a broadest range of metabolites by a single ana-
lytical platform, will be developed. Large-scale, prospec-
tive studies are required to relate the metabolic profile of
FF to the developmental potential of human oocytes and
to apply this non-invasive technology to clinics.
Conclusion
Ideally FF, a superfluous, abundant and easily available
material in IVF cycles, would be an optimal source on
non-invasive predictors of oocyte quality. Unfortunately,
however, most studies aiming to find a good molecular
predictor of oocyte quality in FF are mainly correlative
and not performed on large-scale, prospective and well-
controlled basis. Furthermore, most of them analyze the
correlation between specific molecules and the oocyte
performance using univariate, and not multivariate, anal-
ysis algorhythms. As a consequence, until now no single
substance has been identified as a reliable marker of
oocyte competence to fertilization, embryo development
and pregnancy.
The metabolomic approach is a powerful tool to study
such marker(s) in FF, but its application is still at the
beginning; this techniques is facing the problems arising
from analysing a complex biological fluid such as FF.
Hopefully integrated criteria, taking together oocyte mor-
phology, molecular predictors in FF and data about gene
espression in granulosa cells, would give more precise
information and will help embryologists to achieve a bet-
ter capability of selecting optimal quality, "golden"
oocytes in the next years.Reproductive Biology and Endocrinology 2009, 7:40 http://www.rbej.com/content/7/1/40
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